The current COVID-19 pandemic has underlined the importance of non-invasive, reliable diagnostic tests for monitoring in both the community as well as healthcare settings. The unmet clinical need is disproportionately higher for the minorities, and aboriginal populations. This could be due to inadequate representation in the clinical trials and/or other population specific biological factors.
Shani Biotech was founded in 2019 with support from private investors and financial institutions. Our mission is to develop a novel non-invasive and portable technology to measure important blood biomarkers. We are committed to develop an inclusive technology, with reliable clinical applications across all races and ethnicities.